v3.23.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets (in thousands):
March 31, 2023December 31, 2022
Cash and cash equivalents$34,046 $39,019 
Restricted cash, non-current64 64 
Total cash, cash equivalents and restricted cash $34,110 $39,083 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets (in thousands):
March 31, 2023December 31, 2022
Cash and cash equivalents$34,046 $39,019 
Restricted cash, non-current64 64 
Total cash, cash equivalents and restricted cash $34,110 $39,083 
Schedule of Inventory
Details of inventory are presented as follows (in thousands):
March 31, 2023December 31, 2022
Raw materials$2,911 $944 
Work in process— — 
Finished goods892 917 
Total $3,803 $1,861 
Property, Plant and Equipment
Details of property and equipment are presented as follows (in thousands):
March 31, 2023December 31, 2022
Computers and Software$366 $338 
Construction in process1,805 77 
Furniture and fixtures65 65 
Leasehold improvements129 129 
Total$2,365 $609 
Accumulated depreciation(140)(101)
Property and equipment, net$2,225 $508 
Schedule Of Gross-To-Net Sales Adjustments
The following table sets forth the changes in the accrued revenue allowances (in thousands):
Balance at Beginning of YearProvision for Current Period SalesPaymentsBalance at March 31, 2023
For the Three Months Ended March 31, 2023$1,434 $1,035 $(553)$1,916 
Balance at Beginning of YearProvision for Current Period SalesPaymentsBalance at March 31, 2022
For the Three Months Ended March 31, 2022$— $407 $— $407 
Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share
The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted net loss per share because their inclusion would be anti-dilutive (in thousands):
Three Months Ended March 31,
20232022
Options to purchase common stock3,846 2,028 
Warrants to purchase common stock29 29